Moldova latest patents query
The latest invention patents collect the data information of Moldova invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
Novel antibodies targeting CD3 and another target and uses thereof
PendingMDE20260313A1
Owner:ANTENGENE BIOLOGICS LTD
Non-therapeutic use of an NADH preparation combined with sports
PendingMDE20260280A1
Owner:NUTROPIA GROUP GMBH
A method of valorising a solid waste product
PendingMDE20260124A1
Owner:UNIVERSITY OF THE WITWATERSRAND
Validation of natural matrices for therapeutic use on humans, animals and plants on bio-physical bases as an alternative to validation through chemically definable substances derived from said matrices by isolation and / or synthesis processes and also as an alternative to products comprising natural matrices validated on the basis of their traditional use
PendingMDE20260597A1
Owner:BIOS-THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH SPA IT
Lanifibranor for use in the treatment of splanchnic vasodilatation in a patient with a liver condition
PendingMDE20260279A1
Owner:INVENTIVA
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
PendingMDE20260151A1
Owner:REGENERON PHARMACEUTICALS INC
Dustbin entirely made of plastic, recyclable, with facilitated assembly and disassembly for maintenance
PendingMDE20260696A1
Owner:SOLUTION ITALY SRL
Compounds and pharmaceutical compositions that degrade SWI / SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A
PendingMDE20260325A1
Owner:PLEXIUM INC
Compositions and methods for the treatment of disorders related to frataxin deficiency
PendingMDE20260208A1
Owner:VOYAGER THERAPEUTICS INC
Benzothia(dia)zepine compounds for treatment of HBV and HDV
PendingMDE20260034A1
Owner:ASSEMBLY BIOSCIENCES INC
Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract
PendingMDE20260120A1
Owner:TILLOTS PHARMA AG
Use of an anti-TGFβR2 / PD-1 bispecific antibody to treat cancer
PendingMDE20260158A1
Owner:INCYTE CORP
Protective aminoacid agents for use in peritoneal dialysis
PendingMDE20260063A1
Owner:ZYTOPROTEC FLEXIBLE KAPITALGESELLSCHAFT
Methods for determining when a natural therapeutic or beneficial product exerts its therapeutic or beneficial effect through a physiological mode of action
PendingMDE20260580A1
Owner:BIOS-THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH SPA IT
Interleukin-2 variant proteins that facilitate covalent chemical conjugation and uses thereof
PendingMDE20260499A1
Owner:DEPTH CHARGE LTD
Ligand-cytotoxicity drug conjugates and pharmaceutical uses thereof
PendingMDE20260136A1
Owner:HANSOH BIO LLC +2
A portable riveting device for riveting with self-tapping blind rivets
PendingMDE20260521A1
Owner:ETRN SRO
Compounds and adjuvant formulations useful in pneumococcal vaccines
PendingMDE20260253A1
Owner:MERCK SHARP & DOHME LLC
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
PendingMDE20260437A1
Owner:ACCELERON PHARMA INC
Compositions comprising darunavir, cobicistat, emtricitabine and tenofovir alafenamide for use in the treatment of HIV
PendingMDE20260549A1
Owner:JANSSEN SCI IRELAND UC +1
Methods of treating lymphoma with bispecific antibodies against CD3 and CD20
PendingMDE20260154A1
Owner:GENMAB AS
Means and methods for preparing engineered target proteins by genetic code expansion in a target protein-selective manner
PendingMDE20260185A1
Owner:EURO LAB FUER MOLEKULARBIOLOGIE EMBL
Lifting device and method for controlling or regulating the energy and the energy flow performance in a hoist
PendingMDE20260037A1
Owner:FISCHER SEBASTIAN
Additive manufacturing in metal underframes for plants
PendingMDE20260001A1
Owner:TGM KANIS TURBINEN GMBH
Oligonucleotides for use in modulating immune responses against hepatitis B viral infection
PendingMDE20260193A1
Owner:AUSPERBIO THERAPEUTICS INC
Daratumumab, bortezomib, lenalidomide and dexamethasone for treating multiple myeloma
PendingMDE20260613A1
Owner:JANSSEN BIOTECH INC
EpigenAU / 11: a natural matrix with therapeutic activity through a physiological network mechanism of action (not pharmacological) for restoring homeostasis in tissues inflitrated by cancer cells
PendingMDE20260440A1
Owner:BIOS-THERAPY PHYSIOLOGICAL SYSTEMS FOR HEALTH SPA IT
Compositions comprising a bispecific GPRC5D / CD3 antibody
PendingMDE20260048A1
Owner:JANSSEN BIOTECH INC
Apparatus, system and method for producing an ionized gas discharge for treatment of a medium
PendingMDE20260403A1
Owner:GREEN LIGHTNING SOLUTIONS LLC
System for rescuing from a rescue vehicle such as a ship, or the coast, a shipwrecked person or a bather in difficulty in the sea, or any other body of water, and rescue method adopting such a system
PendingMDE20260083A1
Owner:ARDISSON ETTORE +1
Pharmaceutical composition containing dipeptidyl peptidase small molecule inhibitor
PendingMDE20260102A1
Owner:HAISCO PHARM PTE LTD
Polypeptide derivative for oral delivery
PendingMDE20260293A1
Owner:HANG ZHOU SCIWIND BIOSCIENCES CO LTD +1
Bispecific molecular degraders of pathogenic proteins
PendingMDE20260655A1
Owner:BIOHAVEN THERAPEUTICS LTD
Combination of antibody-drug conjugate and anti-PD-1 antibody, and use thereof
PendingMDE20260163A1
Owner:GENEQUANTUM HEALTHCARE (SUZHOU) CO LTD
Somatostatin subtype receptor 3 (SSTR3) agonists and uses thereof
PendingMDE20260402A1
Owner:CRINETICS PHARMACEUTICALS INC
CCM, preparation method therefor and use thereof
PendingMDE20260302A1
Owner:SHANGHAI H RAY S & T CO LTD
Activatable tyrosine-protein kinase membrane receptor (ROR) antibody-drug conjugates and uses thereof
PendingMDE20260415A1
Owner:EXELIXIS INC
Humanized MUC1 antibody and antibody drug conjugate
PendingMDE20260454A1
Owner:SUN PHARMA ADVANCED RESEARCH CO LTD
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
PendingMDE20260209A1
Owner:MODERNATX INC
Genetic sequence in solanaceous plants having improved resistance to tospovirus
PendingMDE20260682A1
Owner:TERA SEEDS SOCIETÀ A RESPONSABILITÀ LTD CONSORTILE IT
Bispecific stealth lipid nanoparticle compositions for cell targeting
PendingMDE20260701A1
Owner:GENERATION BIO CO
Developer replenishing container and developer replenishing system
PendingMDE20260108A1
Owner:CANON KK
Pharmaceutical composition of furazidin for vaginal administration
PendingMDE20260683A1
Owner:ADAMED PHARMA SA
4-Pyrazolo[1,5-a]pyridin-2-yl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine derivatives as mutant PAH protein stabilizers for the treatment of phenylketonuria
PendingMDE20260530A1
Owner:AGIOS PHARMACEUTICALS INC
Purification of viruses and viral like particles
PendingMDE20260180A1
Owner:INTERIUS BIOTHERAPEUTICS INC
Bifunctional degraders of galactose-deficient immunoglobulins
PendingMDE20260219A1
Owner:BIOHAVEN THERAPEUTICS LTD
Compositions and methods for administering paltusotine to patients with hepatic impairment
PendingMDE20260138A1
Owner:CRINETICS PHARMACEUTICALS INC
JAK inhibitor with a vitamin D analog for treatment of skin diseases
PendingMDE20260267A1
Owner:INCYTE CORP
Pharmaceutical compositions comprising (2S)-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide
PendingMDE20260005A1
Owner:ASTRAZENECA AB
Combination of a WEE1 inhibitor and a PKMYT1 inhibitor
PendingMDE20260564A1
Owner:DEBIOPHARM INTERNATIONAL SA
Battery management system and method with auxiliary power source
PendingMDE20260281A1
Owner:PALMER ENERGY TECHNOLOGY LTD
Antibodies binding to fibroblast activation protein alpha and death receptor 4
PendingMDE20260356A1
Owner:GENMAB AS
Rnai agents for hepatitis b virus infection
PendingMDE20260227A1
Owner:ARROWHEAD PHARMACEUTICALS INC +1
Developer replenishing container and developer replenishing system
PendingMDE20260439A1
Owner:CANON KK
Dosing regimens and related compositions and methods
PendingMDE20260404A1
Owner:APELLIS PHARMACEUTICALS INC
Derivatives of imidazo[1,2-a]pyridine with anti-inflammatory activity
PendingMDE20260368A1
Owner:UNIV DE VALENCIA +4
Crystalline salts or amorphous forms of 2-((1H-pyrazol-3-yl)methyl)-6-((6-aminopyridin-2-yl)methyl)-4-methyl-4,6-dihydro-5H-thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one
PendingMDE20260252A1
Owner:AGIOS PHARMACEUTICALS INC
Communication network with reduced resource full optical meshing
PendingMDE20260021A1
Owner:DEUTSCHE TELEKOM AG
Combination therapies with bi-specific anti-EGFR / c-Met antibodies and anti-PD-1 antibodies
PendingMDE20260082A1
Owner:JANSSEN BIOTECH INC
Compound for regulating activity of microRNA-124
PendingMDE20260541A1
Owner:JIANGSU CHIA TAI FENGHAI PHARMA CO LTD
Electronic injection device for a compressed-air engine, compressed-air engine provided with such a device and hybrid drive train comprising such an engine
PendingMDE20260503A1
Owner:VILLENEUVE PIERRE
Method and plant for manufacturing composite cement and composite cement
PendingMDE20260067A1
Owner:KARTULI CEMENT LLC
CRISPR nuclease polypeptides and gene editing systems comprising such
PendingMDE20260130A1
Owner:ARBOR BIOTECHNOLOGIES INC
Pharmaceutically acceptable salt of a CD47-SIRP alpha pathway inhibitor
PendingMDE20260673A1
Owner:AURIGENE ONCOLOGY LIMITED
Composition comprising iota-carrageenan for the treatment of dry eyes, non-viral conjunctivitis and allergic ocular conditions
PendingMDE20260353A1
Owner:UNITHER PHARMA INC
Melanocortin subtype-2 receptor (MC2R) antagonist for the treatment of ACTH-dependent Cushing's syndrome
PendingMDE20260146A1
Owner:CRINETICS PHARMACEUTICALS INC
Edge seal for manufacturing two-pane or multi-pane insulating glass or solar modules comprising a photocured acrylic sealant composition as secondary sealant
PendingMDE20260075A1
Owner:TENACHEM LTD +1
Pharmaceutical compositions comprising viral particles and methods of using the same
PendingMDE20260139A1
Owner:INTERIUS BIOTHERAPEUTICS INC
Sealed single-dose container of levothyroxine aqueous solution suitable for oral administration
PendingMDE20260570A1
Owner:TSETI IOULIA
Needle assembly and fluid delivery system with needle assembly
PendingMDE20260319A1
Owner:ELI LILLY & CO
Compounds for upregulating utrophin levels in muscle cells and method of application thereof
PendingMDE20260164A1
Owner:PEPTRIS TECH PTE LTD
Dosage regime of crinecerfont for treating congenital adrenal hyperplasia in a pediatric subject
PendingMDE20260233A1
Owner:NEUROCRINE BIOSCIENCES INC
Use of charged air ions in cosmetic treatments
PendingMDE20260176A1
Owner:WETLING IP AEAM LTD ROAD TOWN
Footwear comprising a device for stabilization and walking assistance
PendingMDE20260669A1
Owner:BASE PROTECTION SRL
Fixed dose combinations of cedazuridine and azacitidine
PendingMDE20260506A1
Owner:TAIHO PHARMA CO LTD
Stabilized trimeric RSV fusion proteins without a heterologous trimerzation domain
PendingMDE20260024A1
Owner:MSD INT BUSINESS GMBH
Compositions and methods for the treatment of congenital adrenal hyperplasia
PendingMDE20260257A1
Owner:CRINETICS PHARMACEUTICALS INC
Infill material for turfs and method for obtaining such infill material
PendingMDE20260451A1
Owner:MAR PROJECT SRL
Filter unit with encased glass fragments and arrangement of such units in a pool water filtration system
PendingMDE20260529A1
Owner:K O B
Methods of treating cancer with a combination of a TAAxCD3 bispecific antibody and a targeted immunocytokine
PendingMDE20260642A1
Owner:REGENERON PHARMACEUTICALS INC
Methods and processes to enable RNN-GNN-based network digital twin for O-RAN
PendingMDE20260442A1
Owner:DELL PROD LP
Bifunctional small molecules to target the selective degradation of circulating proteins
PendingMDE20260218A1
Owner:BIOHAVEN THERAPEUTICS LTD
Composition for improving the aesthetic appearance of hair and skin appendages
PendingMDE20260027A1
Owner:GIULIANI SPA
A system and method for producing chopped strands for the manufacture of chopped strand mats
PendingMDE20260615A1
Owner:GROUPE GAZECHIM COMPOSITES SAS
Mixture of 3 isomers of a phthalocyanine derivative
PendingMDE20260311A1
Owner:L MOLTENI & C DEI FRAT ALITTI SOC DI ESERCIZIO SPA